SIETES :: 93212 citas

Resultados de la búsqueda por CEFTRIAXONA REFINAR BÚSQUEDA

1.

Salvador R. Los laboratorios reconvierten sus fábricas para combatir el coronavirus. La Vanguardia 2020:13 de abril. [Ref.ID 103582]

2.

Teng C, Walter EA, Gaspar DKS, Obodozie-Ofoegbu OO, Frei CR. Torsades de pointes and QT prolongation associations with antibiotics: A pharmacovigilance study of the FDA adverse event reporting system. International Journal of Medical Sciences 2019;16:julio. [Ref.ID 103207]

3.

Ross JDC, Brittain C, Cole M, Dewsnap C, Harding J, Hepburn T, Jackson L, Keogh M, Lawrence T, Montgomery AA, Roberts TE, Sprange K, Tan W, Thandi S, Wilson J, Duley L, on behalf of the G-ToG trial team. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial. Lancet 2019:2 de mayo. [Ref.ID 103140]

4.

Taylor SN, Marrazzo J, Batteiger BE, Hook III EW, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, Mueller J. Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea. N Engl J Med 2018;379:8 de noviembre. [Ref.ID 102865]

5.

Laatikainen O, Mietttunen J, Sneck S, Lehtiniemi H, Tenhunen O, Turpeinen M. The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis. Eur J Clin Pharmacol 2017;73:1539-49. [Ref.ID 102145]

6.

Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Zaffiro A, Caruso C, Quaratino D. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of alternative cephalosporins. J Allergy Clin Immunol 2015;136:685-91. [Ref.ID 99527]

7.

Anónimo. Ceftobiprole médocaril. Prescrire 2015;35:331-5. [Ref.ID 99133]

8.

Anónimo. Pertes d'auditions d'origine médicamenteuse. Prescrire 2014;34:428-35. [Ref.ID 97948]

9.

Anónimo. Gonococcie urogénitale. Ceftriaxone en premier choix probabiliste, avec azithromycine contre les Chlamydia. Prescrire 2014;34:282-6. [Ref.ID 97443]

10.

Anónimo. Ceftaroline fosamil. Un autore antibiotique intraveineux, sans plus. Prescrire 2013;33:657. [Ref.ID 96184]

11.

Vodovar D, LeBeller C, Mégarbane B, Lillo-Le-Louet A, Hanslik T. Drug fever: a descriptive cohort study from the French National Pharmacovigilance Database. Drug Saf 2012;35:759-67. [Ref.ID 93643]

12.

Anónimo. Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep 2012;61:590-4. [Ref.ID 92898]

13.

Lenzer J. Pfizer settles with victims of Nigerian drug trial. BMJ 2011;343:d5268. [Ref.ID 91894]

14.

Molyneux E, Nizami SQ, Saha S, Huu KT, Azam M, Bhuta ZA, Zaki R, Weber MW, Qazi SA, for the CSF 5 Study Group. 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study. Lancet 2011;377:1837-45. [Ref.ID 90854]

15.

Snape MD, Kelly DF. Fine with five? Shorter antibiotic courses for childhood meningitis. Lancet 2011;377:1809-10. [Ref.ID 90841]

16.

Kelland K. Scientists find first superbug strain of gonorrhea. REUTERS 2011:1. [Ref.ID 90798]

17.

Anónimo. Méropénem dans diverses infections de plus. Toujours pas d'avantage clinique. Prescrire 2010;30:808. [Ref.ID 89591]

18.

Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823-32. [Ref.ID 87959]

19.

Thaver D, Zaidi AKM, Critchley J, Azmatullah A, Madni SA, Bhutta ZA. A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ 2009;338:1371. [Ref.ID 86002]

20.

Parry CM, Beeching NJ. Treatment of enteric fever. BMJ 2009;338:1340-1. [Ref.ID 86001]